Cited by 576Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.

Drug treatments in Alzheimer’s disease

Open access

Briggs, Robert, Kennelly, Sean P, O’Neill, Desmond·2016·Clinical Medicine

DOI 10.7861/clinmedicine.16-3-247PMC PMC5922703

Open this paper in CoChat — free account Open PDF

Abstract

Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease. Studies of potential disease-modifying therapy have generally been undertaken in patients with clinically detectable disease, yet evidence suggests that the pathological changes associated with AD begin several years before this. It is possible that pharmacological therapy may be beneficial in this pre-clinical stage before the neurodegenerative process is established. Techniques providing earlier diagnosis, such as cerebrospinal fluid biomarkers and amyloid positron emission tomography neuroimaging, are key to testing this theory in clinical trials. Recent results from trials of agents such as aducanumab are encouraging but must also be interpreted with caution. Such medicines could potentially delay the onset of dementia and would therefore markedly reduce its prevalence. However, we currently remain a good distance away from clinically available disease-modifying therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.7861/clinmedicine.16-3-247

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Untitled work
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194
Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960

Show all 76 references

Research works printed but not linked: 1

Mosconi, 2010, Pre-clinical detection of Alzheimer’s disease using FDG-PET, with or without amyloid imaging, J Alzheimers Dis, 20, 843, 10.3233/JAD-2010-091504 · DOI

Sorted by citations

Items 201–300 of 576

Alkaloids in Uncaria rhynchophylla improves AD pathology by restraining CD4+ T cell-mediated neuroinflammation via inhibition of glycolysis in APP/PS1 mice
Kuang, Y., Zhu, M., Gu, H., Tao, Y., Huang, H., & Chen, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118273 · Cited by 17
The role of ferritinophagy and ferroptosis in Alzheimer’s disease
Chen, Z., Zheng, N., Wang, F., Zhou, Q., Chen, Z., Xie, L., Sun, Q., Li, L., & Li, B. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149340 · Cited by 21
Neuroprotection and improvement of the histopathological and behavioral impairments in a murine Alzheimer’s model treated with Zephyranthes carinata alkaloids
Cortés, N., Sabogal-Guáqueta, A. M., Cardona‐Gómez, G. P., & Osorio, E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.013 · Cited by 17
Effects of Co-Administration of Icariin and Panax notoginseng Saponins on Intestinal Microbiota and Hippocampal Protein Expression in a Mouse Model of Alzheimer’s Disease
Zhang, T., Dong, K., Xiao, L., Li, G., & Zhang, Z. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s253972 · Cited by 16
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents
Franchini, S., Linciano, P., Puja, G., Tait, A., Borsari, C., Denora, N., Iacobazzi, R. M., Brasili, L., & Sorbi, C. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00129 · Cited by 15
Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
Hefner, M., Baliga, V., Amphay, K., Ramos, D., & Hegde, V. K. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.721858 · Cited by 18
Circ_0002945 functions as a competing endogenous RNA to promote Aβ25-35-induced endoplasmic reticulum stress and apoptosis in SK-N-SH cells and human primary neurons
Li, G., Liang, R., Lian, Y., & Zhou, Y. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147878 · Cited by 15
Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures
Hernando, S., Nikolakopoulou, P., Voulgaris, D., Hernández, R. M., Igartúa, M., & Herland, A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00315-1 · Cited by 15
Using the Montreal cognitive assessment to identify individuals with subtle cognitive decline.
Cersonsky, T. E. K., Mechery, S., Carper, M. M., Thompson, L. I., Lee, A. K. W., Alber, J., Sarkar, I. N., & Brick, L. A. D. (2022) · Neuropsychology · doi:10.1037/neu0000820 · Cited by 17
Inhibitory Effects of Macelignan on Tau Phosphorylation and Aβ Aggregation in the Cell Model of Alzheimer's Disease
Gu, L., Cai, N., Li, M., Bi, D., Yao, L., Fang, W., Wu, Y. L., Hu, Z., Liu, Q., Lin, Z., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.892558 · Cited by 15
A Review on Phyto-Therapeutic Approaches in Alzheimer’s Disease
Sahiner, M., Yilmaz, A. S., Güngör, B., & Şahiner, N. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14010050 · Cited by 16
Impaired muscle function, including its decline, is related to greater long‐term late‐life dementia risk in older women
Radavelli‐Bagatini, S., Macpherson, H., Scott, D. S., Daly, R. M., Hodgson, J. M., Laws, S. M., Zhu, K., Prince, R. L., Lewis, J. R., & Sim, M. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13227 · Cited by 14
Machine learning identification and immune infiltration of disulfidptosis‐related Alzheimer's disease molecular subtypes
Zhu, Y., Kong, L., Han, T., Yan, Q., & Liu, J. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.1037 · Cited by 15
Nanostructured Lipid Carriers Made of Ω-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases
Hernando, S., Herrán, E., Hernández, R. M., & Igartúa, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100928 · Cited by 15
Adult Hippocampal Neurogenesis and Alzheimer's Disease: Novel Application of Mesenchymal Stem Cells and their Role in Hippocampal Neurogenesis.
Noureddini, M., & Bagheri-Mohammadi, S. (2021) · PubMed Central · doi:10.22088/ijmcm.bums.10.1.1 · Cited by 16
Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies
Shahrivar‐Gargari, M., Hamzeh‐Mivehroud, M., Hemmati, S., Mojarrad, J. S., Küçükkılınç, T. T., Ayazgök, B., & Dastmalchi, S. (2021) · Archiv der Pharmazie · doi:10.1002/ardp.202000453 · Cited by 15
Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations
Bukhari, S. N. A. (2021) · Current Drug Delivery · doi:10.2174/1567201818666210910162750 · Cited by 16
The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer’s disease
Zhao, X., Li, X., She, L., Li, L., Huang, P. C., & Liang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113188 · Cited by 15
Chronic glucocorticoid exposure accelerates Aβ generation and neurotoxicity by activating calcium-mediated CN-NFAT1 signaling in hippocampal neurons in APP/PS1 mice
Ding, S., Liu, Y., Huang, L., Kong, L., Chen, M., Su, Y., Li, X., Dong, X., Han, Y., Li, W., et al. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113407 · Cited by 15
The significance of glycolysis index and its correlations with immune infiltrates in Alzheimer’s disease
Qiu, Z., Bai, X., Ji, X., Wang, X., Han, X., Wang, D., Jiang, F., & An, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960906 · Cited by 15
Functional MRI technologies in the study of medication treatment effect on Alzheimer's disease
Guo, H., Grajauskas, L. A., Habash, B., D’Arcy, R. C. N., & Song, X. (2018) · Aging Medicine · doi:10.1002/agm2.12017 · Cited by 15
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders
Nguyen, T. T., Nguyen‐Thi, P., Nguyen, T. H. A., Ho, T.-T., An, T. N. M., Toi, V. V., & Giau, V. V. (2023) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-023-00654-1 · Cited by 14
Gene therapy: an alternative to treat Alzheimer’s disease
Doshi, V., Joshi, G., Sharma, S., & Choudhary, D. K. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02873-z · Cited by 14
Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer’s pathologies?
Manoharan, S. D., Hamid, H. A., Hashim, N. F. M., Cheema, M. S., Chiroma, S. M., Mustapha, M., & Mehat, M. Z. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148793 · Cited by 14
ocial and economic determinants and potential for growth in life expectancy of the population in the Russian Federation taking into account regional differentiation
Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 1., Зайцева, Н. В., Onishchenko, G. G., Popova, A. Y., Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 1., Kleyn, S. V., Kiryanov, D. A., & Glukhikh, M. V. (2019) · Health Risk Analysis · doi:10.21668/health.risk/2019.4.02.eng · Cited by 14
Status and future directions of clinical trials in Parkinson's disease
Söderbom, G. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.009 · Cited by 14
Therapeutic potential of extracellular vesicles in neurodegenerative disorders
Roudi, S., Rädler, J., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00017-5 · Cited by 14
Exploring the therapeutic potential of acridines: Synthesis, structure, and biological applications
Marques, D. S. C., Lima, L. D. S., Miranda, J. F. D. O. M., Santos, C. Á. D. A., Filho, I. J. D. C., & de Lima, M. D. C. A. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108096 · Cited by 13
Identification of Blood-Based Glycolysis Gene Associated with Alzheimer’s Disease by Integrated Bioinformatics Analysis
Wang, F., Xu, C., Chen, W., Duan, S., Xu, S., Dai, J., & Wang, Q. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210540 · Cited by 12
Multi-target regulatory mechanism of Yang Xin Tang − a traditional Chinese medicine against dementia
Lo, T. Y., Chan, A. S. L., Cheung, S. T., Yung, L. Y., Leung, M. M. H., & Wong, Y. H. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00813-w · Cited by 16
Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
Kakraba, S., Ayyadevara, S., Mainali, N., Balasubramaniam, M., Bowroju, S., Penthala, N. R., Atluri, R., Barger, S. W., Griffin, S. T., Crooks, P. A., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16101498 · Cited by 10
Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer’s Disease: A Pilot Study
Wang, X., Zimmermann, H. R., Lockhart, S. N., Craft, S., & Ma, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191189 · Cited by 12
Aconiti lateralis Radix Praeparata inhibits Alzheimer’s disease by regulating the complex regulation network with the core of GRIN1 and MAPK1
Wang, Y., Zhang, H., Wang, J., Yu, M., Zhang, Q., Yan, S., You, D., Shi, L., Zhang, L., Wang, L., et al. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1900879 · Cited by 12
A new arylsulfanyl-benzo-2,1,3-thiadiazoles derivative produces an anti-amnesic effect in mice by modulating acetylcholinesterase activity
Rodrigues, K. D. C., de Oliveira, R. L., Chaves, J. D. S., da Rocha, V. M. E., dos Santos, B. F., Fronza, M. G., Domingues, N. L. C., Savegnago, L., Wilhelm, E. A., & Luchese, C. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109736 · Cited by 13
Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer’s Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer’s Disease
Das, S., Ramachandran, A. K., Halder, D., Akbar, S., Ahmed, B., & Joseph, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220629162229 · Cited by 13
Protein quality control of N-methyl-D-aspartate receptors
Benske, T. M., Mu, T., & Wang, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.907560 · Cited by 12
Mechanism of the Fibroblast Growth Factor 23/α-Klotho Axis in Peripheral Blood Mononuclear Cell Inflammation in Alzheimer’s Disease
Li, B., Zhou, M., Peng, J. Y., Yang, Q., Chu, J., Li, R., & Jiang, Y. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1970180 · Cited by 12
Alzheimer's disease: an epidemiological analysis over the number of hospitalizations and deaths in Brazil
Piovesan, E. C., de Freitas, B. Z., Lemanski, F. C. B., & Carazzo, C. A. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1767827 · Cited by 17
Enhancing Therapeutic Efficacy of Donepezil, an Alzheimer’s Disease Drug, by Diplazium esculentum (Retz.) Sw. and Its Phytochemicals
Inthachat, W., Chantong, B., Pitchakarn, P., Takoon, C., Karinchai, J., Suttisansanee, U., & Temviriyanukul, P. (2024) · Pharmaceuticals · doi:10.3390/ph17030341 · Cited by 14
How do HCN channels play a part in Alzheimer's and Parkinson's disease?
Zhang, Z., Luo, X., Jiang, L., Wu, H., & Tan, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102436 · Cited by 12
Longitudinal Assessment of Retinal Microvasculature in Preclinical Alzheimer's Disease
Curro‐Tafili, K. R., van Nispen, R. M. A., den Braber, A., van de Giessen, E., van de Kreeke, J. A., Tan, H. S., Visser, P. J., Bouwman, F. H., & Verbraak, F. D. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.2 · Cited by 12
AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin
Sun, H., Gao, X., Niu, J., Chen, P., He, S., Xu, S., & Ge, J. (2024) · eneuro · doi:10.1523/eneuro.0310-24.2024 · Cited by 12
1,3,5-Triazine: A Promising Molecular Scaffold for Novel Agents for the Treatment of Alzheimer’s Disease
Silva, C. F. M., Guerrinha, A. P. D. D. M. S., Carvalho, S., Pinto, D. C. G. A., & Silva, A. M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030882 · Cited by 12
Intranasal administration of stem cell derivatives for the treatment of AD animal models: a systematic review and meta-analysis
Hua, Z., Zhou, N., Zhou, Z., Fu, Z., Guo, R., Akogo, H. Y., Yang, J.-Y., Yu, M., Jiang, Y., Lan, S., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04555-4 · Cited by 12
Inhibitory Effect of Hexahydrocurcumin on Memory Impairment and Amyloidogenesis in Dexamethasone-Treated Mice
Jearjaroen, P., Pakdeepak, K., Tocharus, C., Chaichompoo, W., Suksamrarn, A., & Tocharus, J. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00269-y · Cited by 13
Gait Characteristics and Cognitive Function in Middle-Aged Adults with and without Type 2 Diabetes Mellitus: Data from ENBIND
Herings, P. M. R., Dyer, A. H., Kennelly, S., Reid, S., Killane, I., McKenna, L., Bourke, N. M., Woods, C. P., O’Neill, D. J., Gibney, J., et al. (2022) · Sensors · doi:10.3390/s22155710 · Cited by 12
Self-citation
MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis
Li, S., Wu, L., Ma, M., Yang, L.-X., & Qin, C. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3598 · Cited by 11
Lycopene: Sojourn from kitchen to an effective therapy in Alzheimer's disease
Kapoor, B., Gulati, M., Rani, P., Kochhar, R. S., Atanasov, A. G., Gupta, R., Sharma, D., & Kapoor, D. N. (2022) · BioFactors · doi:10.1002/biof.1910 · Cited by 13
Mesenchymal Stem Cells for Treating Alzheimer’s Disease: Cell Therapy and Chemical Reagent Pretreatment
Zhang, K., Du, X., Gao, Y., Liu, S., & Xu, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221253 · Cited by 12
Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review)
Zhou, S., Tu, L., Chen, W., Yan, G., Guo, H., Wang, X., Hu, Q., Liu, H., & Li, F. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12351 · Cited by 12
[Types and number of hobbies and incidence of dementia among older adults: A six-year longitudinal study from the Japan Gerontological Evaluation Study (JAGES)].
Ling, L., Tsuji, T., Nagamine, Y., Miyaguni, Y., & Kondo, K. (2020) · PubMed · doi:10.11236/jph.67.11_800 · Cited by 12
Bis(ethylmaltolato)oxidovanadium (IV) alleviates neuronal apoptosis through regulating peroxisome proliferator-activated receptor γ in a triple transgenic animal model of Alzheimer’s disease
He, Z., Song, J., Li, X., Li, X., Zhu, H., Wu, C., Xiao, W. H., Du, X., Ni, J., Li, N., et al. (2021) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-021-01874-8 · Cited by 12
Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress
Bilski, R., Dąbkowski, S., Kozieł, I., Kozicki, M., Małachowska, A., Przygocki, M., & Tyska, O. (2025) · Biomolecules · doi:10.3390/biom15091345 · Cited by 13
Exosomes in Alzheimer’s disease: From pathogenesis to therapeutics—A comprehensive review of diagnostic and drug delivery applications
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 11
Cognition and Health Ageing
Briggs, R., Kennelly, S., & O’Neill, D. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-06200-2_15 · Cited by 12
Self-citation
Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities
Cheng, J. J., Fairchild, J. K., McNerney, M. W., Noda, A. M., Ashford, J. W., Suppes, T. M., Chao, S. Z., Taylor, J. L., Rosen, A. C., Durazzo, T. C., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210349 · Cited by 11
Nanozymes in Alzheimer's disease diagnostics and therapy
Li, L., Zhang, W., Cao, H., Fang, L., Wang, W., Li, C., He, Q., Jiao, J., & Zheng, R. (2024) · Biomaterials Science · doi:10.1039/d4bm00586d · Cited by 12
Extraction, characterization, and neuroprotective effects of polysaccharides the stems of Panax ginseng C. A. Meyer by three different solvents (water, acid, alkali)
Zhang, X., Hu, Z., Duan, Y., Jiang, Y., Xu, W., Yang, P., We, Z., Sun, J., & Li, G. (2024) · Industrial Crops and Products · doi:10.1016/j.indcrop.2024.119512 · Cited by 11
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases
Ore, A., Angelastro, J. M., & Giulivi, C. (2024) · Brain Sciences · doi:10.3390/brainsci14090899 · Cited by 14
A promising drug repurposing approach for Alzheimer's treatment: Givinostat improves cognitive behavior and pathological features in APP/PS1 mice
Gao, Q.-C., Liu, G.-L., Wang, Q., Zhang, S., Ji, Z., Wang, Z., Wu, M., Yu, Q., & He, P. F. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103420 · Cited by 11
Effect of a single nonpharmacological intervention on cognitive functioning in older adults with mild-to-moderate Alzheimer's disease: A meta-analysis of randomized controlled trials
Chen, K., Zhao, X., & Zhou, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100050 · Cited by 11
N‐Substituted Arylidene‐3‐(Methylsulfonyl)‐2‐Oxoimidazolidine‐1‐Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study
Tok, F., Sağlık, B. N., Özkay, Y., Kaplancıklı, Z. A., & Koçyiğit‐Kaymakçıoğlu, B. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200265 · Cited by 12
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
Singh, S. P., Yang, F., Sivils, A., Cegielski, V., & Chu, X. (2022) · Biomolecules · doi:10.3390/biom12070996 · Cited by 11
Merocyanine Complexes Coupled with Plasmonic Au Nanoparticles for Inhibiting Tau Aggregation
Wu, Y.-C., Wu, C.-Y., Tsai, S.-W., Chen, H.-J., Liu, W.-J., Lin, D., Gong, T., Yong, K., & Kong, K. V. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c03326 · Cited by 11
UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes
Novák, M., Svobodová, B., Konecny, J., Kuratkova, A., Nevosadova, L., Prchal, L., Korábečný, J., Lauschke, V. M., Soukup, O., & Kučera, R. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115154 · Cited by 10
Stem cell-conditioned medium is a promising treatment for Alzheimer's disease
Alidoust, L., Akhoondian, M. J., Atefi, A. H., Keivanlou, M., Hedayati, M., & Jafari, A. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114543 · Cited by 11
Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
Wu, X.-L., Li, Z., Chen, G., Yin, Y., & Chen, C. Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1227371 · Cited by 12
The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease
He, Z., Zhang, H., Li, X., Tu, S., Wang, Z., Han, S., Du, X., Shen, L., Li, N., & Liu, Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154555 · Cited by 12
Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases
Scotti, L., Rodrigues, T. C. M. L., de Sousa, N. F., dos Santos, A. M. F., Guimarães, R. D. A., & Scotti, M. T. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230126112628 · Cited by 11
Pharmacological evaluation of newly synthesized benzimidazole derivative for anti-Alzheimer potential
Ahmed, A., Khan, A., Nadeem, H., Imran, M., & Irshad, N. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2138382 · Cited by 10
NEK7 inhibition attenuates Aβ42-induced cognitive impairment by regulating TLR4/NF-κB and the NLRP3 inflammasome in mice
Li, P., He, Y., Yang, Q., Guo, H., Li, N., & Zhang, D. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-105 · Cited by 10
Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer’s Disease: A Systematic Review
Rossi, E., Marrosu, F., & Saba, L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230852 · Cited by 10
A Dual-Modality Complex-Valued Fusion Method for Predicting Side Effects of Drug-Drug Interactions Based on Graph Neural Network
Kang, C., Zhang, H., & Yin, Y. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3422673 · Cited by 10
Efficacy of Transcranial Direct Current Stimulation and Photobiomodulation in Improving Cognitive Abilities for Alzheimer’s Disease: A Systematic Review
Cornea, M., Vintilă, B. I., Bucuță, M. D., Ștef, L., Anghel, C. E., Grama, A. M., Lomnășan, A., Ștețiu, A. A., Boicean, A., Sava, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051766 · Cited by 12
Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease
Tocci, D. R., Fogel, M., Gupta, V., Kim, P. S.-H., Latimer, J. J., Adlimoghaddam, A., Robison, L. S., & Albensi, B. C. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01706-w · Cited by 13
Potential Role of Lymphovenous Bypass in Mitigating Alzheimer's Disease Dementia
Xie, Q., Pak, C. J., Kwon, J. G., Chao, S., & Hong, J. P. (2025) · Archives of Plastic Surgery · doi:10.1055/a-2627-9243 · Cited by 10
The Multi-Dimensional Action Map of Resveratrol Against Alzheimer’s Disease: Mechanism Integration and Treatment Strategy Optimization
Liu, Y., Dong, Y., Cao, Z., Ji, Y., Cheng, X., & Zheng, X. (2025) · Nutrients · doi:10.3390/nu17213451 · Cited by 12
Golgi-Cox impregnation combined with fluorescence staining of amyloid plaques reveals local spine loss in an Alzheimer mouse model
Kartalou, G.-I., Endres, T., Leßmann, V., & Gottmann, K. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108797 · Cited by 14
Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics
Kirk, R. D., Picard, K. L., Christian, J. A., Johnson, S. L., DeBoef, B., & Bertin, M. J. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00686 · Cited by 10
Neurochemical changes underlying cognitive impairment in olfactory bulbectomized rats and the impact of the mGlu5-positive allosteric modulator CDPPB
Płoska, A., Cieślik, P., Siekierzycka, A., Kalinowski, L., & Wierońska, J. M. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147577 · Cited by 10
Chemical Profiling and Antioxidant and Anti-Amyloid Capacities of Salvia fruticosa Extracts from Greece
Ververis, A., Kyriakou, S., Ioannou, K., Chatzopoulou, P. S., Panayiotidis, M. I., Plioukas, M., & Christodoulou, K. (2023) · Plants · doi:10.3390/plants12183191 · Cited by 12
Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease
Zhuang, J., Gao, J., Yin, Y., Gong, B., Ji, W., Chen, X., Li, P., Cheng, W., Zhao, Y., & He, B. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220214092824 · Cited by 10
Germacrone alleviates okadaic acid-induced neurotoxicity in PC12 cells via M1 muscarinic receptor-mediated Galphaq (Gq)/phospholipase C beta (PLCβ)/ protein kinase C (PKC) signaling
Lin, M., Li, P., Liu, W., Niu, T., & Huang, L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2036918 · Cited by 10
Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
Maciejewska, K., Czarnecka, K., Kręcisz, P., Niedziałek, D., Wieczorek, G., Skibiński, R., & Szymański, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115876 · Cited by 12
Fiscalin Derivatives as Potential Neuroprotective Agents
Barreiro, S., Silva, B., Long, S., Pinto, M. M. M., Remião, F., Sousa, E., & Silva, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071456 · Cited by 9
Comparative Study of Chemical Composition and Cholinesterase Inhibition Potential of Essential Oils Isolated from Artemisia Plants from Croatia
Politeo, O., Cajic, I., Simic, A., Ruščić, M., & Bektašević, M. (2023) · Separations · doi:10.3390/separations10100546 · Cited by 9
Evolving significance of kinase inhibitors in the management of Alzheimer's disease
Ansari, M. M., Sahu, S. K., Singh, T. G., Singh, S. R. J., & Kaur, P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176816 · Cited by 9
Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Hydrogel: A promising new technique for treating Alzheimer’s disease
Gong, B., Cheng, W., Ji, W., Chen, X., Chu, J., Liang, W., He, B., Zhuang, J., Yin, Y., & Gao, J. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0008 · Cited by 9
SOCIAL AND ECONOMIC DETERMINANTS AND POTENTIAL FOR GROWTH IN LIFE EXPECTANCY OF THE POPULATION IN THE RUSSIAN FEDERATION TAKING INTO ACCOUNT REGIONAL DIFFERENTIATION
Federal Service for Surveillan ce on Consumer Rights Protection and Human Wellbeing, 1., Зайцева, Н. В., Onishchenko, G. G., Popova, A. Y., Federal Service for Surveillan ce on Consumer Rights Protection and Human Wellbeing, 1., Kleyn, S. V., Kiryanov, D. A., & Glukhikh, M. V. (2019) · Health Risk Analysis · doi:10.21668/health.risk/2019.4.02 · Cited by 9
AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes
Driscoll, I. F., Ma, Y., Lose, S. R., Gallagher, C. L., Johnson, S. C., Asthana, S., Hermann, B. P., Sager, M. A., Blennow, K., Zetterberg, H., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12383 · Cited by 8
Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer’s disease
Lai, Y., Han, L., Chen, M., Lin, X., Wu, L., Zhao, Y., Lin, F., & Lin, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1115202 · Cited by 9
Protective effect of glutamic-oxaloacetic transaminase on hippocampal neurons in Alzheimer's disease using model mice
Li, H., Zhang, D., Wang, X., Wang, S., & Xiao, M. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137194 · Cited by 11
The network pharmacology study and molecular docking to investigate the potential mechanism of Acoritataninowii Rhizoma against Alzheimer's Disease
Qiu, Z.-K., Zhou, B.-X., Pang, J., Zeng, W.-Q., Wu, H.-B., & Yang, F. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01179-6 · Cited by 13
Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
Strell, P., Johnson, S. T., Carchi, C., & Low, W. C. (2023) · Cell Transplantation · doi:10.1177/09636897231164712 · Cited by 10
Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment
Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., & Dinet, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042272 · Cited by 9
Dementia, disclosing the diagnosis
Briggs, R., McHale, C., Fitzhenry, D., O’Neill, D. J., & Kennelly, S. (2017) · QJM · doi:10.1093/qjmed/hcx181 · Cited by 9
Self-citation
Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms
Nelson, R. S., Dammer, E. B., Santiago, J. V., Seyfried, N. T., & Rangaraju, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.902146 · Cited by 10
Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model
Kim, J., Kang, S., & Chang, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810602 · Cited by 8
The Quest for Neurodegenerative Disease Treatment—Focusing on Alzheimer’s Disease Personalised Diets
Palimariciuc, M., Balmuș, I.-M., Gireadă, B., Ciobica, A. S., Chiriță, R., Iordache, A.-C., Apostu, M., & Dobrin, R. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45020098 · Cited by 9

Authors: Briggs, R., Kennelly, S. P., & O’Neill, D.
Affiliations: Tallaght University Hospital (IE)
ORCID: Briggs, Robert
O’Neill, Desmond
Venue: Clinical Medicine
Publisher: Elsevier BV
Published: 2016-06
Volume: 16
Issue: 3
Pages: 247-253
ISSN: 1470-2118 (ISSN-L)
DOI: 10.7861/clinmedicine.16-3-247
PMC: PMC5922703
OpenAlex: W2415242066
Cited by: 571
References: 76
Citations by year: 2026: 37 · 2025: 67 · 2024: 97 · 2023: 79 · 2022: 106 · 2021: 95 · 2020: 55 · 2019: 18 · 2018: 5 · 2017: 9 · 2016: 2
FWCI: 9.13
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2872 d)
Locations: Clinical Medicine (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords: Alzheimer's disease, pharmacotherapy, disease-modifying therapy, symptomatic treatment, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid PET, aducanumab, early diagnosis, dementia prevention
MeSH terms: Alzheimer Disease, Amyloid, Cholinesterase Inhibitors, Humans, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug treatments in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks